189 related articles for article (PubMed ID: 19713988)
1. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
2. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.
Tleyjeh IM; Bin Abdulhak AA; Riaz M; Alasmari FA; Garbati MA; AlGhamdi M; Khan AR; Al Tannir M; Erwin PJ; Ibrahim T; Allehibi A; Baddour LM; Sutton AJ
PLoS One; 2012; 7(12):e50836. PubMed ID: 23236397
[TBL] [Abstract][Full Text] [Related]
3. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
Villafuerte-Gálvez JA; Kelly CP
Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and the risk for Clostridium difficile infection.
Famularo G; Gasbarrone L; De Simone C
JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
[No Abstract] [Full Text] [Related]
6. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
7. Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.
Inghammar M; Svanström H; Voldstedlund M; Melbye M; Hviid A; Mølbak K; Pasternak B
Clin Infect Dis; 2021 Jun; 72(12):e1084-e1089. PubMed ID: 33629099
[TBL] [Abstract][Full Text] [Related]
8. Exposure to Gastric Acid-Suppression Therapy Is Associated With Health Care- and Community-Associated Clostridium difficile Infection in Children.
Jimenez J; Drees M; Loveridge-Lenza B; Eppes S; delRosario F
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):208-11. PubMed ID: 25806678
[TBL] [Abstract][Full Text] [Related]
9. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
[TBL] [Abstract][Full Text] [Related]
10. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM
Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
13. How much do PPIs contribute to C. difficile infections?
Leontiadis GI; Miller MA; Howden CW
Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
[TBL] [Abstract][Full Text] [Related]
14. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection in the community: are proton pump inhibitors to blame?
Freedberg DE; Abrams JA
World J Gastroenterol; 2013 Oct; 19(40):6710-3. PubMed ID: 24187445
[TBL] [Abstract][Full Text] [Related]
16. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
17. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?
Cunningham R; Dial S
J Hosp Infect; 2008 Sep; 70(1):1-6. PubMed ID: 18602190
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy.
Akhtar AJ; Shaheen M
J Natl Med Assoc; 2007 May; 99(5):500-4. PubMed ID: 17534007
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
20. Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection.
Nerandzic MM; Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2009 Oct; 53(10):4133-7. PubMed ID: 19667292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
